Our innovative products and technologies define a new era in current and future diagnostic and therapeutic radiopharmaceuticals.
We lead the way in producing stable, reliable, domestically-sourced, environmentally-friendly radioisotope supply to meet critical patient healthcare needs and advance clinical research.
Our people drive our solutions in advancing radioisotope technology to shape a better world.
We are a recognized, emerging global leader with a proven track record and strong vision for the future of radiopharmaceuticals. Our innovation-driven technology is transforming the landscape for medical radioisotope production and distribution around the world.
NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones
Read More >NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)
Read More >NorthStar Medical Radioisotopes to Participate in Upcoming Oppenheimer & Co. Inc. Event, “Radiopharmaceutical Therapies Come of Age”
Read More >NorthStar Medical Radioisotopes Expands Management Team with Appointment of Adam Lynch as Vice President, Corporate Development and External Affairs
Read More >